Skip to main content
Graph
Search
fr
|
en
Login
Search
All
Categories
Concepts
Courses
Lectures
MOOCs
People
Practice
Publications
Startups
Units
Show all results for
Home
Lecture
Immunotherapy: Antibody-Based Strategies
Graph Chatbot
Related lectures (32)
Previous
Page 2 of 4
Next
Tumor Immunology: Immune Responses and Cancer Therapy
Covers immune responses to tumors, cancer therapy, and challenges in personalized cancer vaccines and combination therapies.
Antigen Recognition by T cells
Explores the principles of antigen recognition by T cells, including antigen capture, MHC processing, and T cell responses.
Immune System: T Cells and Antigen Presentation
Explores T cells, antigen presentation, cytotoxicity, MHC proteins, apoptosis, and vaccine principles.
Immunoediting of Tumors: Experimental Evidence and Mechanisms
Explores tumor immunoediting, mechanisms of tumor escape, and cancer immunotherapy, emphasizing immune response regulation and recent drug approvals.
Immune Cell Engineering
Explores immune cell engineering, including targeting strategies, microneedle technology, and advancements in CAR-T cell therapy.
Design of Immunogenic Vaccines
Explores the design of immunogenic vaccines, boosting immune response through various methods, and addressing challenges in vaccine development.
Immune Engineering: Cancer Immunotherapy Strategies
Explores cancer immunotherapy strategies, including blocking inhibitory pathways, increasing effector T cells, and enhancing cancer vaccines.
Experimental Evidence for Immunoediting of Tumors
Explores experimental evidence supporting immunoediting of tumors and the use of immunotherapy to enhance antitumor immune responses.
Activation and Differentiation of T Cells
Explores the activation and differentiation of T lymphocytes, focusing on naive T cells recognizing antigens and differentiating into effector and memory cells.
Immune Tissue Engineering: Mechanisms and Applications
Explores immune tissue engineering, focusing on cell manipulation, immune cell types, and adaptive immune response levels, highlighting the importance of engineering immune cells for targeted therapies.
